Interruption of Inhaled Corticosteroid Therapy in COPD Can Reduce Risk of Pneumonia Lung Disease News
Researchers from McGill University in Canada showed that interruption of inhaled corticosteroid therapy in Chronic Obstructive Pulmonary Disease may lead to significant reduction in the risk of serious pneumonia. The study entitled “Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia” was published this June in Chest. […]